drugset / Trial / NCT03571919

Lidocaine Infusions for Rib Fractures

NCT03571919 ↗

Phase 4 Withdrawn Stanford University
RandomizedParallel-groupTriple-blindTreatment

Summary

Patients with traumatic rib fractures not receiving regional anesthesia through a epidural or nerve block catheter will be recruited for the study. Once enrolled, they will be randomized to receive either intravenous lidocaine or intravenous saline for control of pain related to their rib fractures. In addition, they will receive other pain medications, such as acetaminophen, gabapentin, and opioid pain medications. Our primary outcome is a decrease in their opioid medication requirements.

Timeline

Start
2018-06-15
Primary completion
2019-06-01
Completion
2019-07-01

Outcome

Outcome not reported

Stopped (Enrollment): “Inability to recruit during the Covid pandemic”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 1 mg/kg Intravenous

Indications

No indication recorded.